Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Globus Medical Inc
(NY:
GMED
)
72.70
+0.61 (+0.85%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical Inc
< Previous
1
2
3
4
5
6
7
Next >
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
January 11, 2024
Via
Benzinga
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
January 10, 2024
From
Globus Medical
Via
GlobeNewswire
NYSE:GMED qualifies as a high growth stock and is consolidating.
January 09, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via
Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
December 25, 2023
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via
Chartmill
Assessing Globus Medical: Insights From 5 Financial Analysts
December 20, 2023
Via
Benzinga
NYSE:GMED: a strong growth stock preparing for the next leg up?.
November 17, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Expert Ratings for Globus Medical
November 08, 2023
Via
Benzinga
Globus Medical: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
October 23, 2023
NYSE:GMED, a growth stock which is not overvalued.
Via
Chartmill
3 Stocks at the Forefront of Medical Robotics
December 10, 2023
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
December 04, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing.
Via
Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
November 13, 2023
Despite its growth, NYSE:GMED remains within the realm of affordability.
Via
Chartmill
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
November 07, 2023
GMED earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Globus Medical Reports Third Quarter 2023 Results
November 07, 2023
From
Globus Medical
Via
GlobeNewswire
What 8 Analyst Ratings Have To Say About Globus Medical
October 20, 2023
Via
Benzinga
The Latest Analyst Ratings for Globus Medical
September 05, 2023
Via
Benzinga
Where Globus Medical Stands With Analysts
August 04, 2023
Via
Benzinga
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
August 03, 2023
GMED earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
October 20, 2023
Via
Benzinga
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
October 10, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
September 27, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
September 19, 2023
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
September 19, 2023
Via
Benzinga
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
September 07, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Completes Merger with NuVasive
September 01, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Reports Second Quarter 2023 Results
August 03, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
July 31, 2023
MARVEL™ is Globus Medical’s second major release this year in the pediatric scoliosis space
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 13, 2023
From
Globus Medical
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.